Clinical trial Recruiting at 1 site Interventional Ages 4 to 7

Pelargonium graveolens essential oil as a pulpotomy agent for primary teeth

Official title: Clinical and Radiographic Evaluation of Pelargonium Graveolens Essential Oil as a Pulpotomy Agent in Primary Teeth

Run by Tanta University · NCT07386925 · Data updated 2026-11-12

This study tests whether rose geranium oil can be used as a pulpotomy medicament in kids’ primary molars to preserve tooth function.

More Reversible Pulpitis trials

Quick facts

Study typeInterventional
Ages4 Years to 7 Years
SexAll
Enrollment30 (estimated)
SponsorTanta University
Academic / other
Locations2 sites (Tanta, Cairo Governorate and 1 other locations)
StatusRecruiting
StartedFebruary 5, 2026
Main results expectedOctober 2026
Study endsNovember 2026
Registry record updatedSeptember 18, 2026
Trial IDNCT07386925 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children with restorable primary molars affected by reversible pulpitis or requiring pulpotomy due to deep caries.

Probably not a fit

Patients with irreversible pulpitis, non-restorable teeth, or signs of periapical pathology may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial evaluates the use of Pelargonium graveolens essential oil as an alternative pulpotomy medicament in restorable primary molars with reversible pulpitis. It focuses on safety and performance compared with standard expectations for maintaining tooth vitality and structure. The approach leverages the oil’s antimicrobial and biocompatible properties, aiming to reduce inflammation and promote favorable healing. Participants are children requiring pulpotomy in primary molars, with careful screening for radiographic and clinical criteria. The investigation adheres to clinical research standards and prioritizes patient safety and ethical considerations.

Why it matters

Potential benefit: If successful, children may benefit from a more biocompatible pulpotomy agent that preserves tooth integrity and function.

How similar studies have gone: Other studies in dental materials show promise for plant-derived agents, but this specific use as a pulpotomy medicament is relatively novel with limited clinical data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Restorable primary molars with deep carious lesions.
* Absence of gingival swelling or sinus tract.
* Absence of spontaneous pain
* Absence of pain on percussion.
* Absence of discontinuity of lamina dura
* Absence of internal root resorption.
* Absence of external root resorption.
* Absence of inter-radicular or periapical bone destruction (radiolucency).

Exclusion Criteria:

* presence of spontaneous pain
* presence of gingival swelling or sinus tract
* presence of internal or external root resorption
* pain on percussion.

Where it's running

  • faculty of dentistry, Tanta university
    Tanta, Cairo Governorate, Egypt
    Recruiting
  • faculty of dentistry, Tanta university
    Tanta, Egypt
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.